bristol-myers squibb pfizer alliance logo

Please select the link below to access information relevant to you.

hcp icon Healthcare Professionals

CONTINUE CONTINUE

Report adverse events (Healthcare Professionals in the Republic of Ireland)

Reporting of suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product.

Healthcare professionals are asked to report any suspected adverse reactions via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

Adverse reactions should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com.

Report side effects (Patients and Public in the Republic of Ireland)

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet.

You can also report side effects directly via Freepost, HPRA Pharmacovigilance, Earlsfort Terrace, IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517; Website: www.hpra.ie; E-mail: medsafety@hpra.ie.

By reporting side effects you can help provide more information on the safety of this medicine.

Side Effects should also be reported to Bristol-Myers Squibb Medical Information on 1 800 749 749 or medical.information@bms.com.

You may contact our EU Data Protection Officer at EUDPO@BMS.com to exercise any data privacy rights that you may have, as well as to raise any concerns or questions in relation to the handling of your personal data by Bristol-Myers Squibb Company.

  • Privacy Policy
  • Legal Notice
  • Pharmacovigilance Notice
  • Contact Us
bristol-myers squibb pfizer alliance logo 2
  • Privacy Policy
  • Legal Notice
  • Pharmacovigilance Notice
  • Contact Us

© 2019 Bristol-Myers Squibb Company

All corporate names and logos of Bristol-Myers Squibb and Pfizer and/or their products are trademarks of Bristol-Myers Squibb and Pfizer products. All rights reserved over the content of this website.

Pharmacovigilance Notice: This website has not been designed and must not be used to collect or provide safety information related to Bristol-Myers Squibb products. If your query relates to an adverse event experienced by a patient, please contact the Pharmacovigilance Department on 1 800 749 749 (Ireland only freephone number) or +44 1895 523740 (international number) which is available 24 hours a day, 365 days a year, or contact us by email at medical.information@bms.com.

Your use of this website is subject to the Legal Notice, the Privacy and Cookie Policy, the Pharmacovigilance Notice and the applicable laws and regulations.

Mercury reference: 432IE1904723-01
Date of preparation: August 2020

You are about to leave this website

This link takes you to a website of Bristol-Myers Squibb Group or Pfizer Group that may have a different purpose, contents which might not be appropriate for all kinds of public as per the applicable laws, or may have different terms and conditions. The Alliance recommends that you check whether it is suitable for you as per its intended audience and the applicable laws and regulations before accessing it.

If you wish to continue click ‘Continue’, otherwise click ‘Stay on this site’.

Continue Stay on this site

You are about to leave this Website.

This link takes you to an external website that may have a different purpose, contents which might not be appropriate for all kinds of public as per the applicable laws, or may have different terms and conditions. The Alliance between Bristol-Myers Squibb Group & Pfizer Group recommends that you check whether it is suitable for you as per its intended audience and the applicable laws and regulations before accessing it.

If you wish to continue, click ‘Continue’, otherwise click ‘Stay on this site’.

Continue Stay on this site